Tag Archives: ACOs
Obamacare After Nov 6th: Trouble for Pharma?
by Tom Norton
No doubt the November 6th election is going to be close, very close: close for the Presidency, close for the Senate, and possibly close for the House. So close, in fact, it’s possible that no substantial political change will occur in Washington, as a result.
That said, for the U.S. pharmaceutical industry this is [...]
Posted in Events, FDA, Legal, Market Access, R&D, Regulatory, leadership, pricing Also tagged CER, IPAB, Obamacare, PCORI 3 Comments
Show Me the Money: Exploring Physician Incentive Compensation
A new report from ZS Associates explores the efficacy and impact of physician incentive compensation on the delivery of quality care; when incentives fall short, so can patient outcomes.
Posted in Op-Ed, Strategy Also tagged physician incentive compensation, ZS Associates Leave a comment

Physicians in ACOs Dare Pharma to Step up Its Game